, 2009, Shi et al., 2010 and Vandenberghe et al., 2005; solubilization efficiency of ∼60%, Figure S1B). Both CL-47

and CL-91 preserved high-molecular-weight AMPAR complexes (Schwenk et al., 2009) as demonstrated by blue native polyacrylamide gel electrophoresis (BN-PAGE); the AMPAR complexes focused over an apparent molecular mass range of ∼0.4 MDa under either condition, although they appeared slightly smaller in CL-91 than in CL-47 (Figure 1A). Total eluates of APs with the anti-GluA ABs or with pools of preimmunization immunoglobulins G (IgG) were analyzed by high-resolution nanoflow liquid chromatography tandem mass spectrometry (nano-LC MS/MS), which provided data on both the identity and the amount of proteins. Protein amounts were determined ATM inhibitor from the peak volumes (PVs) of their best-correlating tryptic peptides (TopCorr method [ Bildl et al., 2012]; see also Experimental Procedures), a label-free quantification method offering a linear dynamic range of up to four orders of magnitude ( Bildl et al., 2012, Müller et al., 2010 and Schwenk ABT-263 in vivo et al., 2010). The results of these MS analyses showed that AMPARs were retained in all APs with high efficiency as reflected by the PV values and the extensive coverage provided for the primary sequence of the GluA1-4 proteins by the

MS/MS-identified peptides (relative sequence coverage of 90%, 95%, 95%, 83% for GluA1 to GluA4, respectively; Tables S1–S3; detailed information on all aspects related to MS analyses were deposited at http://www.channel-proteomes.com/projects). The other proteins see more identified by mass spectrometry in the anti-GluA APs (and surpassing the threshold PV, see Experimental Procedures) were evaluated for both their specificity and consistency of copurification

with the GluA proteins based on the quantitative data of protein amounts. Specificity of copurification was determined from abundance ratio plots using both target knockouts and preimmunization IgGs as negative controls (upper-right quadrant in Figure 1B; Table S3; Bildl et al., 2012 and Müller et al., 2010). Consistency was assessed by the number of specific copurifications of a given protein across the anti-GluA APs; a protein was considered consistent if it was specifically retained in at least five (out of ten) or three (out of five) anti-GluA APs using solubilization with CL-91 and CL-47, respectively. Together, the criteria abundance threshold, specificity, consistency, and confirmation by at least one of the knockout controls defined a sharp-profiled proteome (Figure 1C), identifying 34 (out of 1,711 detected) proteins as high-confidence constituents of native AMPARs in the rodent brain (Table 1).